India's Strides responds to FDA, continues shipments to U.S
MUMBAI (Reuters) - Strides Arcolab, the latest Indian drug firm to draw U.S. regulators' scrutiny over manufacturing practices, has answered June quer...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/qRLTFhrI_7E/story01.htm
No comments:
Post a Comment